Moderators: ziploc_1 , zmanindc , rafunrafun , rosemountbomber , golf stud , Number sleven
Search This Board: 
Created: 03/12/2007 10:02:49 PM - Followers: 1082 - Board type: Free - Posts Today: 0

AMARIN TICKER RELATED LINKS
Amarin Webpage
NASDAQ AMRN Quote 
Y! Finance AMRN Landing Page 
Seeking Alpha AMRN Landing Page
FinViz AMRN Landing Page


VASCEPA RELATED LINKS & Outside Organizational News
The EPA Drug Initiative (EPADI)
Vascepa Savings Card Program
FDA Orange Book entry for Vascepa
Vascepa Prescribing Information
Vascepa Marine DTC Patient Brochure
Nissui EPA Synthesis History & Methodology
FDA Approval of Vascepa for the Reduction of Triglyceride Levels ≥ 500mg/dL (26 Jul 2012)
Pure EPA Vascepa Now Available in Half-Gram Capsule Size (25 Oct 2016)
ADA’s 2019 Standards of Medical Care in Diabetes Incorporate Findings from REDUCE-IT (28 Mar 2019)
New 2019 Updates to the European Society of Cardiology and European Atherosclerosis Society’s Guidelines incorporate Reduce-IT (3 Sep 2019)
National Lipid Association’s New Position Statement on Use of Icosapent Ethyl (16 Sep 2019)
Independent Drug-Pricing Assessment Finds Vascepa Cost-Effective (17 Oct 2019)

RELEVANT SOCIAL MEDIA ACCOUNTS
Amarin Instagram - @amarincorp Amarin Twitter - @amarincorp Amarin LinkedIn Amarin ADP Portal - Job Openings Dr. Bhatt Twitter - @DLBHATTMD
TerraPharma Twitter - @TerraPharma1 John Cappello Twitter - @JohnCappello RafunRafun Twitter - @ra_fun K Trivedi Twitter - @GPUWorld  
 

VASCEPA CLINICAL TRIALS + FDA Meetings
Marine & Anchor (Amarin Led)
MARINE Study meets primary endpoints(29 Nov 2010)
ANCHOR Trial meets all Primary and Secondary Endpoints (18 Apr 2011)
Additional Inflammatory Marker Data from Marine and Anchor (22 Jan 2013)
New Clinical Data Showing Significant Reductions in Apolipoprotein C-III Levels in Marine and Anchor (8 April 2013)
FDA AD-Com Outcome for Anchor sNDA (16 October 2013)
FDA delays ANCHOR sNDA (20 Dec 2013)
Presentation of MARINE and ANCHOR analyses at AHA showing significant reduction of remnant-like particle cholesterol (17 Nov 2014)
Marine & Anchor Key Summaries (2017)
Vascepa showed reductions in potentially atherogenic lipids and inflammatory markers – Anchor post-hoc (12 Mar 2018)

REDUCE-IT (Amarin Led)
NIH Clinical Trial Page
Amarin Announces Dosing of First Patient in REDUCE-IT (7 Dec 2011)
Amarin and FDA Reaffirm Concurrence on REDUCE-IT through SPA Agreement Amendment (4 Aug 2016)
Amarin Randomizes Final Patient into REDUCE-IT (31 Aug 2016)
REDUCE-IT to Continue As Planned at Recommendation of Independent Data Monitoring Committee (14 Aug 2017)
REDUCE-IT Meets Primary Endpoint (24 Sep 2018)
REDUCE-IT Displayed 25% RRR in 5-Point MACE (10 Nov 2018)
REDUCE-IT NEJM Article(3 Jan 2019)
REDUCE-IT showed 30% reduction in total Cardiovascular events (18 Mar 2019)
Amarin submits sNDA seeking new indication based on REDUCE-IT (28 Mar 2019)
FDA Grants Priority Review for Vascepa sNDA (29 May 2019)
Amarin Notified of Ad-Com Meeting Planned for Nov 2019 (8 Aug 2019)
REDUCE-IT USA-specific Results released (11 Nov 2019)
FDA AD-Com Outcome for REDUCE-IT sNDA (14 Nov 2019)
REDUCE-IT related data presented at 2019 AHA (18 Nov 2019)


PARTNERSHIPS / OVERSEAS
Amarin and Eddingpharm announce agreement for Vascepa in China (26 Feb 2015)
Amarin and HLS announce agreement for Vascepa in Canada (25 Sep 2017)
Commencement of Vascepa Clinical Development in China (17 Jan 2018)
Biologix and Amarin announce approval of Vascepa in Lebanon for patients with Triglyceride Levels ≥ 500mg/dL (21 Mar 2018)
Amarin & Mochida Announce Collaboration on Future Development of EPA-Based Drug Products and Indications (12 Jun 2018)
Biologix and Amarin announce approval of Vascepa in UAE for patients with Triglyceride Levels ≥ 500mg/dL (26 Jul 2018)
Vascepa granted Priority Review from Health Canada New Drug Submission, anticipated to be filed in April 2019 by HLS (29 Mar 2019)
HLS files New Drug Submission for Vascepa with Health Canada (29 April 2019)


EPA Trials for other indications
Section Pending

Non-Vascepa (AMR-101) Amarin Trials
Section Pending

 

PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#389841
You are correct in that we are just studythosestocks 10/01/2022 11:51:01 PM
#389840
STS, where do you come up with “roughly caddiedad 10/01/2022 11:36:10 PM
#389839
Agreed. Very well could be a game changer studythosestocks 10/01/2022 10:13:27 PM
#389838
study...Your post covers most of the salient points ziploc_1 10/01/2022 10:07:45 PM
#389837
Thank you sir grbnitz4002 10/01/2022 08:26:04 PM
#389836
Thoughtful stuff — thanks! TastyTheElf 10/01/2022 08:25:54 PM
#389835
study...thanks for this insightful discussion ziploc_1 10/01/2022 08:02:25 PM
#389834
I think you have laid it out well rosemountbomber 10/01/2022 07:57:47 PM
#389833
I just wanted to personally thank you (along studythosestocks 10/01/2022 07:43:59 PM
#389832
hey Meow, do you know anything about the lizzy241 10/01/2022 06:28:53 PM
#389831
What I keep gravitating to, is that compared rosemountbomber 10/01/2022 05:28:37 PM
#389830
Diluting would be in his favor so it shadolane 10/01/2022 04:46:00 PM
#389829
Denner also defined his long approach in terms ilovetech 10/01/2022 04:12:38 PM
#389828
Zip, I’d it possible that Denner is privy markroth2 10/01/2022 03:30:33 PM
#389827
Denner has paid a major chunk of money ziploc_1 10/01/2022 03:10:23 PM
#389826
Noel, Thanks - good post ! jasbg 10/01/2022 02:06:17 PM
#389825
Amarin has definitely made a lot of us noelan_s09 10/01/2022 01:34:11 PM
#389824
My question is why he isn't buying more mrmainstreet 10/01/2022 01:18:49 PM
#389823
Of course Denner invested with the intention of shadolane 10/01/2022 12:43:09 PM
#389822
Noelan, I appreciate the kind words. Number sleven 10/01/2022 12:40:40 PM
#389821
Sleven, I share your overall perspective and thoughts on noelan_s09 10/01/2022 11:47:42 AM
#389820
I think he wait for the miracle. TastyTheElf 10/01/2022 09:51:04 AM
#389819
Disagreements are welcomed. Nothing would please me TastyTheElf 10/01/2022 09:50:08 AM
#389818
Completely agree with your statement! He is not markroth2 10/01/2022 09:29:29 AM
#389817
Denner invested $100 million in Amarin ziploc_1 10/01/2022 09:25:56 AM
#389816
TTE, Being that Denner made a mistake, what couldbebetter 10/01/2022 08:40:08 AM
#389815
I could not disagree more. Do you really markroth2 10/01/2022 08:37:21 AM
#389814
"Shadolane, Why did Denner acquire his AMRN stake? TastyTheElf 10/01/2022 08:17:46 AM
#389813
Kiwi, No. You miss my point. The presence Number sleven 10/01/2022 08:03:14 AM
#389812
Shadolane, Why did Denner acquire his AMRN couldbebetter 10/01/2022 07:52:41 AM
#389811
We need a jaw-dropping new indication! TastyTheElf 10/01/2022 07:48:30 AM
#389810
Great to hear Rose Invest83838 10/01/2022 07:16:52 AM
#389809
If BP had any interest in AMRN this shadolane 10/01/2022 07:04:16 AM
#389808
Thanks Kiwi. Power finally on 3 hours rosemountbomber 09/30/2022 10:33:24 PM
#389807
Your pt is that the generic is under Whalatane 09/30/2022 09:53:23 PM
#389806
Kiwi, That is exactly my point. Number sleven 09/30/2022 09:39:33 PM
#389805
N7. Linked by Dr Bhatt Whalatane 09/30/2022 09:33:28 PM
#389804
Meowza, That was funny, and I think accurate. Number sleven 09/30/2022 09:24:09 PM
#389803
He was our second worst option ;-} Meowza 09/30/2022 09:12:42 PM
#389802
Kiwi, You are talking about the US market. Number sleven 09/30/2022 09:12:34 PM
#389801
The only way we see $5.00 or more couldbebetter 09/30/2022 08:25:58 PM
#389800
N7 So the obvious question… if it’s so Whalatane 09/30/2022 08:16:24 PM
#389799
MRM, You answer your own question. Number sleven 09/30/2022 07:59:59 PM
#389798
RMB how did U do thru Ian ? Whalatane 09/30/2022 07:40:41 PM
#389797
Raf. The rebates are to the large healthcare Whalatane 09/30/2022 07:29:17 PM
#389796
Raf, Thanks as always. As you said, it's Number sleven 09/30/2022 07:18:28 PM
#389795
Except that those on Medicare Part D aren't rafunrafun 09/30/2022 07:17:56 PM
#389794
AMRN is not launching a generic To keep Whalatane 09/30/2022 07:13:31 PM
#389793
Thx for the script # Raf Holding above 60k Whalatane 09/30/2022 07:09:49 PM
#389792
GV numbers didn't fully add up this week. rafunrafun 09/30/2022 07:09:30 PM
Post Subject